These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 463893)

  • 41. Feedback control in the management of cardiac arrhythmias.
    Collins SM; Arzbaecher RC
    ISA Trans; 1979; 18(1):95-100. PubMed ID: 457369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction.
    Wyse DG; Kellen J; Rademaker AW
    J Am Coll Cardiol; 1988 Aug; 12(2):507-13. PubMed ID: 3292630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration.
    Sheridan DJ; Crawford L; Rawlins MD; Julian DG
    Lancet; 1977 Apr; 1(8016):824-5. PubMed ID: 67335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Logical approach to lignocaine therapy.
    Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
    Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variability of early lidocaine levels in patients.
    Zito RA; Reid PR; Longstreth JA
    Am Heart J; 1977 Sep; 94(3):292-6. PubMed ID: 888762
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effectiveness of lidocaine use in the initial period of acute myocardial infarct].
    Iosava KV; Areshidze TKh; Lezhava MG; Gaprindashvili TG
    Kardiologiia; 1982 Dec; 22(12):82-5. PubMed ID: 6186836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.
    LeLorier J; Grenon D; Latour Y; Caillé G; Dumont G; Brosseau A; Solignac A
    Ann Intern Med; 1977 Dec; 87(6):700-2. PubMed ID: 931206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.
    Pfeifer HJ; Greenblatt DJ; Koch-Weser J
    Am Heart J; 1976 Aug; 92(2):168-73. PubMed ID: 941829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid prediction of individual dosage requirements for lignocaine.
    Vozeh S; Berger M; Wenk M; Ritz R; Follath F
    Clin Pharmacokinet; 1984; 9(4):354-63. PubMed ID: 6467768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Character of adverse effects of prophylactic lidocaine in the coronary care unit.
    Rademaker AW; Kellen J; Tam YK; Wyse DG
    Clin Pharmacol Ther; 1986 Jul; 40(1):71-80. PubMed ID: 3522031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Lidocain poisoning. 5 patients with letal (2 patients) and reversible course].
    Stadler FX; Herold R; Kistler HJ
    Schweiz Med Wochenschr; 1979 Dec; 109(49):1941-5. PubMed ID: 94179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol.
    Ochs HR; Carstens G; Greenblatt DJ
    N Engl J Med; 1980 Aug; 303(7):373-7. PubMed ID: 7393249
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion.
    Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN
    Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of methods of lidocaine administration in patients.
    Salzer LB; Weinrib AB; Marina RJ; Lima JJ
    Clin Pharmacol Ther; 1981 May; 29(5):617-24. PubMed ID: 7214792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lidocaine therapy with an exponentially declining infusion. Clinical evaluation of an optimized dosing technique.
    Sebaldt RJ; Nattel S; Kreeft JH; Ogilvie RI
    Ann Intern Med; 1984 Nov; 101(5):632-4. PubMed ID: 6486594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant hyperthermia caused by intravenous lidocaine for ventricular arrhythmia.
    Tatsukawa H; Okuda J; Kondoh M; Inoue M; Terashima S; Katoh S; Ida K
    Intern Med; 1992 Aug; 31(8):1069-72. PubMed ID: 1477468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques.
    Alderman EL; Kerber RE; Harrison DC
    Am J Cardiol; 1974 Sep; 34(3):342-9. PubMed ID: 4851926
    [No Abstract]   [Full Text] [Related]  

  • 60. Development of an optimal lidocaine infusion strategy for neonatal seizures.
    Malingré MM; Van Rooij LG; Rademaker CM; Toet MC; Ververs TF; van Kesteren C; de Vries LS
    Eur J Pediatr; 2006 Sep; 165(9):598-604. PubMed ID: 16691409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.